Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

Major histocompatibility complex class I-related chain A (MICA) molecules are frequently expressed in lymphoproliferative malignancies including multiple myeloma (MM). MICA activates NK cells and co-stimulates T cells by interaction with its immunoreceptor NKG2D. In contrast, soluble MICA (sMICA) mo...

Full description

Bibliographic Details
Main Authors:	Rebmann, V, Schütt, P, Brandhorst, D, Opalka, B, Moritz, T, Nowrousian, MR, Grosse-Wilde, H
Format:	Journal article
Language:	English
Published:	2007

Similar Items

The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
by: Schütt, P, et al.
Published: (2008)

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
by: Schütt, P, et al.
Published: (2005)

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
by: Schütt, P, et al.
Published: (2005)

Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
by: Schütt, P, et al.
Published: (2006)

Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification
by: Jiaxuan Xu, et al.
Published: (2022-10-01)

Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma.
by: Schütt, P, et al.
Published: (2005)

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
by: Rasmus Sørrig, et al.
Published: (2017-01-01)

Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma
by: Nowrousian, MR, et al.
Published: (2005)

Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.
by: Nowrousian, MR, et al.
Published: (2005)

Erratum to “Prognostic factors affecting disease-free survival and overall survival in T4 colon cancer”
Published: (2023-10-01)

High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
by: Shijie Zhou, et al.
Published: (2017-01-01)

Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients
by: Schiebel Ingrid, et al.
Published: (2010-12-01)

Prognostic factors for progression‐free and overall survival in malignant pleural mesothelioma
by: Jordi Guzmán‐Casta, et al.
Published: (2021-04-01)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
by: Jiayi Li, et al.
Published: (2022-10-01)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
by: Shijie Zhou, et al.
Published: (2018-01-01)

Post-transplantation Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Lymphoblastic Lymphoma is an Independent Prognostic Factor with an Impact on Progression-Free Survival but not Overall Survival
by: Na Dai MD, et al.
Published: (2021-11-01)

The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer
by: Lishuang Wei, et al.
Published: (2024-02-01)

CGB5 expression is independently associated with poor overall survival and recurrence‐free survival in patients with advanced gastric cancer
by: Yuxin Yang, et al.
Published: (2018-03-01)

Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
by: Vinod Kumar, et al.
Published: (2012-01-01)

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
by: Jingjing Ge, et al.
Published: (2022-10-01)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
by: Hailun Xie, et al.
Published: (2023-02-01)

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen for Overall Survival and Recurrence-Free Survival in Resectable Thymic Epithelial Tumors
by: Yang-Yu Huang MD, et al.
Published: (2022-10-01)

SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE
by: Stergios Intzes, et al.
Published: (2021-01-01)

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer
by: Patrick McGarrah MD, et al.
Published: (2023-06-01)

Improved estimation of overall survival and progression-free survival for state transition modeling
by: Peter C Wigfield, et al.
Published: (2023-12-01)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
by: Bei Wang, et al.
Published: (2022-10-01)

THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
by: Ayşe Uysal, et al.
Published: (2021-11-01)

Prognostic nomograms to predict overall survival and cancer‐specific survival in patients with pelvic chondrosarcoma
by: Li Chen, et al.
Published: (2019-09-01)

Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.
by: Daniela P Ferro, et al.
Published: (2011-01-01)

Development and Validation of a Novel Prognostic Model for Overall Survival in Newly Diagnosed Multiple Myeloma Integrating Tumor Burden and Comorbidities
by: Shuangshuang Jia, et al.
Published: (2022-03-01)

The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen
by: Yanbin Pang, et al.
Published: (2020-09-01)

Prognostic factors affecting overall survival in right colon cancer
by: Mehmet Ince, et al.
Published: (2017-03-01)

Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine
by: Apostolia-Maria Tsimberidou, et al.
Published: (2019-12-01)

Conditional survival in multiple myeloma and impact of prognostic factors over time
by: Nadine H. Abdallah, et al.
Published: (2023-05-01)

Clinical independent prognostic factors and overall survival prognostic nomogram for intracranial subependymoma: A SEER population-based analysis 2004–2016
by: Zibin Zhang, et al.
Published: (2022-08-01)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
by: Shu-Wen Zhang, et al.
Published: (2022-07-01)

Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Head and Neck Mucosal Melanoma
by: Lu Z, et al.
Published: (2022-03-01)

Random survival forest in determination of important risk factors on overall survival and disease-free survival in gastric cancer patients
by: M. Safari, et al.
Published: (2023-07-01)

PHF19 before and post induction treatment possess favorable potency of reflecting treatment response to protease inhibitors, event-free survival, and overall survival in multiple myeloma patients
by: Hongyu An, et al.
Published: (2024-12-01)

Clinical characteristics and overall survival prognostic nomogram for metaplastic breast cancer
by: Caihong Zheng, et al.
Published: (2023-03-01)